Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07396662

Endocrine-exocrine Functions and Prognosis After Pancreatectomy

The Analysis of Endocrine-exocrine Functions and Prognosis After Pancreatectomy

Status
Recruiting
Phase
Study type
Observational
Enrollment
3,500 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Pancreatic diseases often require surgery or invasive procedures to provide a chance for a cure. However, due to the pancreas's unique anatomical structure, its relative position to adjacent organs, and its dual endocrine and exocrine functions, the complexity of surgery is increased, impacting the patient's postoperative quality of life. Therefore, this project aims to retrospectively collect basic data, preoperative and postoperative blood tests (blood cell counts, biochemistry, tumor markers, glucose-related, lipid-related), and preoperative and postoperative imaging examinations (CT, MRI, Ultrasound, PET scan, Endoscopy, etc.) of patients who underwent pancreatic surgery at our hospital. We aim to compare whether surgical methods, lesion margin clearance rates, and postoperative remnant pancreatic volume affect the patient's endocrine function, exocrine function, quality of life, and disease prognosis. This analysis is intended to understand the indications, surgery-related factors, and prognosis for patients planning to undergo pancreatic surgery, with the expectation of providing more diverse and specific treatment recommendations for patients with pancreatic diseases in the future

Conditions

Interventions

TypeNameDescription
PROCEDUREpancreatectomyall procedures demanding pancreatic parenchyma transaction

Timeline

Start date
2016-01-01
Primary completion
2034-12-31
Completion
2034-12-31
First posted
2026-02-09
Last updated
2026-02-09

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT07396662. Inclusion in this directory is not an endorsement.